5FU

DRUG17 trials

Sponsors

NYU Langone Health, Washington University School of Medicine, Amgen, Stanford University, Accelerated Community Oncology Research Network

Conditions

Adenocarcinoma of the Distal EsophagusAdenocarcinoma of the Proximal StomachAdenocarcinomas of the Gastroesophageal JunctionAnal CancerAnterior Tongue Squamous Cell CarcinomaBile Duct CancerCancer of GallbladderCancer of Head and Neck

Phase 1

Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer

TerminatedNCT00463840

NYU Langone HealthPancreatic Cancer

Start: 2004-06-30End: 2015-10-31Updated: 2017-12-05

A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer

TerminatedNCT01671488

Brown UniversityAnal Cancer

Start: 2013-02-28End: 2018-02-28Updated: 2020-02-17

Study of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic Cancer

CompletedNCT02620800

CelgeneMetastatic Pancreas Adenocarcinoma

Start: 2016-01-18End: 2018-10-29Updated: 2019-10-22

Phase 2

Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma

CompletedNCT00682786

Washington University School of MedicineRectal Carcinoma

Start: 2002-10-31End: 2010-08-31Updated: 2017-10-06

A Randomized Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck

CompletedNCT00756444

AmgenSquamous Cell Carcinoma of Head and Neck

Start: 2008-10-21End: 2012-03-30Updated: 2018-11-15

Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation

TerminatedNCT01151761

Stanford UniversityBile Duct Cancer, Cancer of Gallbladder, Cholangiocarcinoma +2

Start: 2011-01-31End: 2012-07-31Updated: 2016-07-29

Panitumumab, Paclitaxel, Carboplatin and 5FU in the Treatment of Potentially Resectable Gastroesophageal Adenocarcinoma

TerminatedNCT01182610

Accelerated Community Oncology Research NetworkAdenocarcinoma of the Distal Esophagus, Adenocarcinoma of the Proximal Stomach, Adenocarcinomas of the Gastroesophageal Junction +1

Start: 2011-04-30End: 2012-03-31Updated: 2012-12-03

A Phase II Trial of Proton Pump Inhibitors With Chemotherapy in Patients With Metastatic Head and Neck Cancer

WithdrawnNCT02013453

University of Michigan Rogel Cancer CenterCancer of Head and Neck

Start: 2013-12-31Updated: 2014-12-02

Role of Neo-adjuvant Chemotherapy in Tongue Preservation in Locally Advanced Squamous Cell Carcinoma of Oral Tongue

HealthCare Global Enterprise Ltd.Anterior Tongue Squamous Cell Carcinoma, Squamous Cell Carcinoma, Tongue Neoplasms

Start: 2016-04-30End: 2017-06-30Target: 30Updated: 2016-12-07

Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver

CompletedNCT03366155

National Cancer Institute (NCI)Colorectal Adenocarcinoma, Colorectal Cancer, Colorectal Cancer With Hepatic Metastases +2

Start: 2019-06-24End: 2025-11-13Updated: 2026-01-08

Pembrolizumab Plus Chemotherapy in 1st Line Treatment of Pancreatic Cancer

Active, not recruitingNCT04447092

Seoul National University HospitalChemotherapy Effect, Pancreatic Cancer

Start: 2020-07-01End: 2025-12-31Target: 77Updated: 2024-04-19

FOLFOXIRI for Neoadjuvant Treatment of High-risk Locally Advanced Colorectal Cancer

West China HospitalFOLFOXIRI Regimen, High-risk Locally Advanced Colorectal Cancer, Neoadjuvant Chemotherapy

Start: 2021-08-02End: 2022-08-02Target: 69Updated: 2021-08-24

The Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal Cancer

RecruitingNCT05628038

Fudan UniversityRecurrent Rectal Cancer

Start: 2022-11-30End: 2025-12-01Target: 93Updated: 2024-10-01

Tislelizumab Combined With Chemotherapy in the Cross-line Treatment of First-line Resistant Advanced Gastric Cancer

Fujian Cancer HospitalGastric Cancer

Start: 2023-07-01End: 2025-06-01Target: 39Updated: 2023-06-22

Phase 3

Phase 3 Study of FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic Cancer

CompletedNCT01926197

Stanford UniversityPancreatic Cancer

Start: 2013-08-14End: 2022-09-30Updated: 2022-10-28

Adjuvant Systemic Chemotherapy With or Without HAI-FUDR in Patients With Resected CRLM

TerminatedNCT03500874

Sun Yat-sen UniversityColorectal Cancer, HAI, Liver Metastases

Start: 2018-05-28End: 2021-08-31Updated: 2024-01-22

Unknown Phase

Chemoradiation and Consolidation Chemotherapy With or Without Oxaliplatin for Distal Rectal Cancer and Watch and Wait

RecruitingNCT05000697

Hospital Alemão Oswaldo CruzConsolidation, Rectal Cancer

Start: 2021-07-14End: 2027-04-30Target: 216Updated: 2024-11-27

Related Papers

Immunotherapy combined with hypofractionated radiotherapy and chemotherapy for locally recurrent rectal cancer (TORCH-R): A prospective, single-arm, two-cohort, phase II trial.

Journal of Clinical Oncology2025-05-28

No operation after short-course radiotherapy followed by consolidation chemotherapy in locally advanced rectal cancer (NOAHS-ARC): study protocol for a prospective, phase II trial.

2025-03-181 citations

Neoadjuvant chemotherapy with FOLFOXIRI for high-risk relapsed locally advanced colon cancer: A single-arm phase II trial.

Journal of Clinical Oncology2025-01-271 citations

Safety and efficacy of adjuvant FOLFOX/FOLFIRI with versus without hepatic arterial infusion of floxuridine in patients following colorectal cancer liver metastasectomy (HARVEST trial): A randomized controlled trial.

2024-11-303 citations

TORCH-R trial protocol: hypofractionated radiotherapy combined with chemotherapy and toripalimab for locally recurrent rectal cancer: a prospective, single-arm, two-cohort, phase II trial

Frontiers in Oncology2023-11-204 citations

A multi-centre randomized controlled trial investigating Consolidation Chemotherapy with and without oxaliplatin in distal rectal cancer and Watch & Wait

BMC Cancer2023-06-1412 citations

Adjuvant systemic chemotherapy with or without hepatic arterial infusion of floxuridine in patients following colorectal cancer liver metastases resection (HARVEST): A prospective, randomized controlled trial.

Journal of Clinical Oncology2023-06-01

Pathological response and safety of FOLFOXIRI for neoadjuvant treatment of high-risk relapsed locally advanced colon cancer: study protocol for a single-arm, open-label phase II trial

BMJ Open2023-01-012 citations

Biomarker-oriented study of pembrolizumab in combination with chemotherapy in chemotherapy-naïve advanced pancreatic cancer: A phase 2 trial-in-progress.

Journal of Clinical Oncology2022-01-19

Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial.

2021-04-2916 citations

Open-label, multicenter, single-arm study of FABLOx (metronomic 5-fluorouracil plus nab-paclitaxel, bevacizumab, leucovorin, and oxaliplatin) in patients with metastatic pancreatic cancer: Phase I results

Annals of Oncology2018-06-011 citations

ADXS11-001 <i>Lm</i>-LLO Immunotherapy, Mitomycin, 5-fluorouracil (5-FU) and Intensity-modulated radiation therapy (IMRT) for Anal Cancer.

Journal of Clinical Oncology2017-05-2011 citations